PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 257 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,307 | -35.6% | 3,988,710 | +2.5% | 0.01% | -28.6% |
| Q2 2023 | $51,737 | +22.7% | 3,889,922 | +6.8% | 0.01% | +16.7% |
| Q1 2023 | $42,173 | +50.5% | 3,641,812 | +6.3% | 0.01% | +20.0% |
| Q4 2022 | $28,023 | -99.9% | 3,425,767 | +1.6% | 0.01% | +66.7% |
| Q3 2022 | $19,584,000 | -56.9% | 3,370,628 | -67.2% | 0.00% | -50.0% |
| Q2 2022 | $45,456,000 | -18.2% | 10,284,090 | +68.5% | 0.01% | 0.0% |
| Q1 2022 | $55,547,000 | -53.0% | 6,104,093 | +4.6% | 0.01% | -45.5% |
| Q4 2021 | $118,212,000 | -18.7% | 5,833,804 | +1.5% | 0.01% | -21.4% |
| Q3 2021 | $145,463,000 | +17.7% | 5,749,336 | +62.6% | 0.01% | +27.3% |
| Q2 2021 | $123,612,000 | +4.8% | 3,534,812 | -0.2% | 0.01% | -8.3% |
| Q1 2021 | $117,927,000 | +37.0% | 3,540,299 | +6.7% | 0.01% | +33.3% |
| Q4 2020 | $86,088,000 | +267.0% | 3,318,740 | +39.6% | 0.01% | +200.0% |
| Q3 2020 | $23,457,000 | +7905.8% | 2,376,593 | +2700.0% | 0.00% | – |
| Q2 2020 | $293,000 | -29.7% | 84,879 | -37.7% | 0.00% | – |
| Q1 2020 | $417,000 | -14.4% | 136,219 | +43.7% | 0.00% | – |
| Q4 2019 | $487,000 | +5.9% | 94,778 | +6.2% | 0.00% | – |
| Q3 2019 | $460,000 | -14.0% | 89,237 | +0.8% | 0.00% | – |
| Q2 2019 | $535,000 | +79.5% | 88,487 | +115.0% | 0.00% | – |
| Q1 2019 | $298,000 | -1.3% | 41,149 | +1.0% | 0.00% | – |
| Q4 2018 | $302,000 | +38.5% | 40,749 | +1.0% | 0.00% | – |
| Q3 2018 | $218,000 | +49.3% | 40,326 | -1.8% | 0.00% | – |
| Q2 2018 | $146,000 | +73.8% | 41,078 | +0.6% | 0.00% | – |
| Q1 2018 | $84,000 | -21.5% | 40,826 | +0.5% | 0.00% | – |
| Q4 2017 | $107,000 | -71.1% | 40,624 | -42.4% | 0.00% | – |
| Q3 2017 | $370,000 | +47.4% | 70,524 | 0.0% | 0.00% | – |
| Q2 2017 | $251,000 | -31.0% | 70,524 | +0.0% | 0.00% | – |
| Q1 2017 | $364,000 | +35.8% | 70,500 | 0.0% | 0.00% | – |
| Q4 2016 | $268,000 | -57.6% | 70,500 | 0.0% | 0.00% | – |
| Q3 2016 | $632,000 | +464.3% | 70,500 | +343.4% | 0.00% | – |
| Q2 2016 | $112,000 | -57.4% | 15,900 | -48.5% | 0.00% | – |
| Q1 2016 | $263,000 | -35.2% | 30,900 | 0.0% | 0.00% | – |
| Q4 2015 | $406,000 | +106.1% | 30,900 | -42.6% | 0.00% | – |
| Q3 2015 | $197,000 | +44.9% | 53,800 | +128.0% | 0.00% | – |
| Q2 2015 | $136,000 | -1.4% | 23,600 | 0.0% | 0.00% | – |
| Q1 2015 | $138,000 | -25.4% | 23,600 | 0.0% | 0.00% | – |
| Q4 2014 | $185,000 | -3.1% | 23,600 | -39.2% | 0.00% | – |
| Q3 2014 | $191,000 | -20.4% | 38,800 | 0.0% | 0.00% | – |
| Q2 2014 | $240,000 | +15.4% | 38,800 | 0.0% | 0.00% | – |
| Q1 2014 | $208,000 | -32.0% | 38,800 | -33.8% | 0.00% | – |
| Q4 2013 | $306,000 | -12.3% | 58,600 | -7.1% | 0.00% | – |
| Q3 2013 | $349,000 | -16.5% | 63,100 | -62.0% | 0.00% | – |
| Q2 2013 | $418,000 | – | 166,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |